Tags

Type your tag names separated by a space and hit enter

U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.
Food Drug Law J. 2007; 62(3):513-28.FD

Authors+Show Affiliations

Stephen A. Goldman Consulting Services, L.L.C., Morris Plains, N.J., USA.

Pub Type(s)

Historical Article
Journal Article

Language

eng

PubMed ID

17915393

Citation

Goldman, Stephen A.. "U.S. Postmarketing Pharmacovigilance Compliance in the Midst of Regulatory Uncertainty." Food and Drug Law Journal, vol. 62, no. 3, 2007, pp. 513-28.
Goldman SA. U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty. Food Drug Law J. 2007;62(3):513-28.
Goldman, S. A. (2007). U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty. Food and Drug Law Journal, 62(3), 513-28.
Goldman SA. U.S. Postmarketing Pharmacovigilance Compliance in the Midst of Regulatory Uncertainty. Food Drug Law J. 2007;62(3):513-28. PubMed PMID: 17915393.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty. A1 - Goldman,Stephen A, PY - 2007/10/6/pubmed PY - 2007/10/30/medline PY - 2007/10/6/entrez SP - 513 EP - 28 JF - Food and drug law journal JO - Food Drug Law J VL - 62 IS - 3 SN - 1064-590X UR - https://www.unboundmedicine.com/medline/citation/17915393/U_S__postmarketing_pharmacovigilance_compliance_in_the_midst_of_regulatory_uncertainty_ DB - PRIME DP - Unbound Medicine ER -